GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chunghwa Chemical Synthesis & Biotech Co Ltd (TPE:1762) » Definitions » Cyclically Adjusted Revenue per Share

Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Cyclically Adjusted Revenue per Share : NT$22.26 (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Chunghwa Chemical Synthesis & Biotech Co's adjusted revenue per share for the three months ended in Mar. 2025 was NT$3.428. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$22.26 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Chunghwa Chemical Synthesis & Biotech Co's average Cyclically Adjusted Revenue Growth Rate was 3.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Chunghwa Chemical Synthesis & Biotech Co was 9.50% per year. The lowest was 7.00% per year. And the median was 7.20% per year.

As of today (2025-05-24), Chunghwa Chemical Synthesis & Biotech Co's current stock price is NT$29.30. Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was NT$22.26. Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted PS Ratio of today is 1.32.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Chunghwa Chemical Synthesis & Biotech Co was 4.80. The lowest was 1.17. And the median was 3.00.


Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted Revenue per Share Chart

Chunghwa Chemical Synthesis & Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.22 18.03 19.73 21.31 22.06

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.60 21.90 22.17 22.06 22.26

Competitive Comparison of Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted PS Ratio falls into.


;
;

Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chunghwa Chemical Synthesis & Biotech Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.428/134.9266*134.9266
=3.428

Current CPI (Mar. 2025) = 134.9266.

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 3.774 100.684 5.058
201509 3.399 100.392 4.568
201512 4.545 99.792 6.145
201603 3.417 100.470 4.589
201606 3.825 101.688 5.075
201609 4.309 101.861 5.708
201612 3.867 101.863 5.122
201703 3.510 102.862 4.604
201706 2.523 103.349 3.294
201709 4.636 104.136 6.007
201712 4.365 104.011 5.662
201803 3.536 105.290 4.531
201806 4.232 106.317 5.371
201809 2.295 106.507 2.907
201812 2.904 105.998 3.697
201903 4.392 107.251 5.525
201906 4.038 108.070 5.042
201909 2.809 108.329 3.499
201912 3.514 108.420 4.373
202003 3.940 108.902 4.882
202006 5.047 108.767 6.261
202009 3.639 109.815 4.471
202012 7.024 109.897 8.624
202103 5.395 111.754 6.514
202106 6.410 114.631 7.545
202109 6.489 115.734 7.565
202112 6.427 117.630 7.372
202203 6.753 121.301 7.512
202206 7.444 125.017 8.034
202209 5.942 125.227 6.402
202212 6.890 125.222 7.424
202303 9.787 127.348 10.369
202306 6.757 128.729 7.082
202309 4.298 129.860 4.466
202312 5.874 129.419 6.124
202403 3.227 131.776 3.304
202406 5.908 132.554 6.014
202409 4.649 133.029 4.715
202412 3.692 133.157 3.741
202503 3.428 134.927 3.428

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Chunghwa Chemical Synthesis & Biotech Co  (TPE:1762) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=29.30/22.26
=1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Chunghwa Chemical Synthesis & Biotech Co was 4.80. The lowest was 1.17. And the median was 3.00.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Chunghwa Chemical Synthesis & Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Dongxing Street, Shulin District, Taipei, TWN
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.

Chunghwa Chemical Synthesis & Biotech Co Headlines

No Headlines